Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice

Journal of Pharmacological Sciences

Volumn 114, Issue 1, 2010, Pages 107-110

  Ide, Soichiro ^a,b   Fujiwara, Shunsuke ^b   Fujiwara, Masayuki ^b   Sora, Ichiro ^c   Ikeda, Kazutaka ^d   Minami, Masabumi ^a   Uhl, George R ^e   Ishihara, Kumatoshi ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Antidepressant; Knockout mouse; opioid receptor

Indexed keywords

MU OPIATE RECEPTOR; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FORCED SWIMMING TEST; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; WILD TYPE;

EID: 77957934334     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10136SC     Document Type: Article

References (15)

1. Amir S. Involvement of endogenous opioids with forced swimming- induced immobility in mice. Physiol Behav. 1982;28:249-251.
2. Molina VA, Heyser CJ, Spear LP. Chronic variable stress or chronic morphine facilitates immobility in a forced swim test: reversal by naloxone. Psychopharmacology (Berl). 1994;114:433-440.
3. Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH. Nonpeptidic δ-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology. 2002;26:744-755.
4. Fichna J, Janecka A, Piestrzeniewicz M, Costentin J, do Rego JC. Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice. Neuropsychopharmacology. 2007;32:813-821.
5. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, et al. Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther. 2003;305:323-330.
6. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, et al. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol Pharmacol. 1994;45:330-334.
7. Sora I, Elmer G, Funada M, Pieper J, Li XF, Hall FS, et al. μ Opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo μ receptor reserve. Neuropsychopharmacology. 2001;25:41-54.
8. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM, et al. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A. 1997;94:1544-1549.
9. Ide S, Sora I, Ikeda K, Minami M, Uhl GR, Ishihara K. Reduced emotional and corticosterone responses to stress in μ-opioid receptor knockout mice. Neuropharmacology. 2010;58:241-247.
10. Berrocoso E, Rojas-Corrales MO, Mico JA. Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice. Neurosci Lett. 2004;363:25-28.
11. Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol. 1986;35:4493-4497.
12. Dawson LA, Nguyen HQ, Geiger A. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Neuropharmacology. 1999;38:1153-1163.
13. Nestler EJ, Alreja M, Aghajanian GK. Molecular control of locus coeruleus neurotransmission. Biol Psychiatry. 1999;46:1131-1139.
14. Segal M. Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J Physiol. 1979;286:401-415.
15. Berrocoso E, Mico JA. In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, α2-adrenergic, and 5-hydroxytryptamine1A receptors. J Pharmacol Exp Ther. 2007;322:101-107.